| Primary |
| Prostate Cancer |
50.0% |
| Product Used For Unknown Indication |
18.3% |
| Acne |
8.3% |
| Hirsutism |
6.7% |
| Alopecia |
3.3% |
| Prostate Examination Abnormal |
3.3% |
| Drug Use For Unknown Indication |
1.7% |
| Gastrointestinal Disorder |
1.7% |
| Hypertension |
1.7% |
| Off Label Use |
1.7% |
| Prostate Cancer Metastatic |
1.7% |
| Thrombosis |
1.7% |
|
| Cholestatic Liver Injury |
7.7% |
| Dyspnoea |
7.7% |
| Hepatitis |
7.7% |
| Interstitial Lung Disease |
7.7% |
| Sepsis |
7.7% |
| Vomiting |
7.7% |
| Adverse Event |
3.8% |
| Alanine Aminotransferase Increased |
3.8% |
| Asthenia |
3.8% |
| Chromaturia |
3.8% |
| Confusional State |
3.8% |
| Dermatitis Exfoliative |
3.8% |
| Drug Intolerance |
3.8% |
| Dysgraphia |
3.8% |
| Gastric Ulcer |
3.8% |
| Hepatic Cirrhosis |
3.8% |
| Hepatic Neoplasm Malignant |
3.8% |
| Hepatitis Acute |
3.8% |
| Hepatitis Fulminant |
3.8% |
| Hepatotoxicity |
3.8% |
|
| Secondary |
| Prostate Cancer |
52.8% |
| Prostate Cancer Stage Iv |
9.6% |
| Prostate Cancer Stage Iii |
8.1% |
| Dementia Alzheimer's Type |
5.1% |
| Cancer Pain |
2.5% |
| Multiple Myeloma |
2.5% |
| Parkinson's Disease |
2.5% |
| Gastritis |
2.0% |
| Hirsutism |
2.0% |
| Acne |
1.5% |
| Benign Prostatic Hyperplasia |
1.5% |
| Hypertension |
1.5% |
| Alopecia |
1.0% |
| Back Pain |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Cardiovascular Disorder |
1.0% |
| Diabetes Mellitus |
1.0% |
| Neoplasm Prostate |
1.0% |
| Product Used For Unknown Indication |
1.0% |
| Reflux Oesophagitis |
1.0% |
|
| Hypercalcaemia |
10.0% |
| Metastases To Bone |
10.0% |
| Interstitial Lung Disease |
7.5% |
| Pulmonary Congestion |
7.5% |
| Cholestasis |
5.0% |
| Dyspnoea |
5.0% |
| Gamma-glutamyltransferase Increased |
5.0% |
| Hepatic Function Abnormal |
5.0% |
| Hepatitis Fulminant |
5.0% |
| Prostate Cancer |
5.0% |
| Speech Disorder |
5.0% |
| Urge Incontinence |
5.0% |
| Urinary Retention |
5.0% |
| Weight Decreased |
5.0% |
| Activated Partial Thromboplastin Time Abnormal |
2.5% |
| Anaemia |
2.5% |
| Arrhythmia |
2.5% |
| Coronary Artery Disease |
2.5% |
| Diarrhoea |
2.5% |
| Foot Fracture |
2.5% |
|
| Concomitant |
| Prostate Cancer Stage Iv |
38.4% |
| Prostate Cancer |
13.5% |
| Product Used For Unknown Indication |
7.3% |
| Drug Use For Unknown Indication |
7.3% |
| Hypertension |
5.3% |
| Prostate Cancer Stage Iii |
3.5% |
| Benign Prostatic Hyperplasia |
3.4% |
| Cancer Pain |
3.0% |
| Constipation |
2.4% |
| Prostate Cancer Stage Ii |
2.2% |
| Diabetes Mellitus |
1.9% |
| Osteoporosis |
1.9% |
| Multiple Myeloma |
1.5% |
| Prostate Cancer Metastatic |
1.5% |
| Gastritis |
1.5% |
| Metastases To Bone |
1.4% |
| Prophylaxis |
1.2% |
| Atrial Fibrillation |
1.1% |
| Hypercholesterolaemia |
0.9% |
| Gastritis Prophylaxis |
0.8% |
|
| Prostate Cancer |
26.4% |
| Prostate Cancer Stage Iv |
21.1% |
| Weight Decreased |
8.3% |
| Death |
6.2% |
| Prostatic Specific Antigen Increased |
4.1% |
| Vomiting |
3.3% |
| Gastric Cancer |
2.9% |
| Renal Failure Acute |
2.9% |
| Viral Infection |
2.9% |
| Osteonecrosis |
2.5% |
| Weight Increased |
2.5% |
| Bladder Cancer |
2.1% |
| Cardiac Failure |
2.1% |
| Interstitial Lung Disease |
2.1% |
| Metastases To Bone |
2.1% |
| Pain |
2.1% |
| Laryngeal Cancer |
1.7% |
| Perineal Pain |
1.7% |
| Pneumonia |
1.7% |
| Sepsis |
1.7% |
|
| Interacting |
| Hormone Therapy |
87.5% |
| Prostate Cancer |
12.5% |
|
|
